Zenpep

DRUG3 trials

Sponsors

Forest Laboratories, AbbVie, Philipp Schuetz

Conditions

Chronic PancreatitisFibrosing ColonopathyMalnutrition

Phase 1

A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

TerminatedNCT01159119

Forest LaboratoriesChronic Pancreatitis

Start: 2010-08-02End: 2011-07-01Target: 15Updated: 2020-01-18

Unknown Phase

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

TerminatedNCT01652157

AbbVieFibrosing Colonopathy

Start: 2012-07-31End: 2020-04-08Updated: 2021-03-22

Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)

RecruitingNCT06826105

Philipp SchuetzMalnutrition

Start: 2025-09-22End: 2026-01-31Target: 20Updated: 2025-09-30